Advertisement

Topics

TARCEVA Company Profile

08:47 EST 13th December 2018 | BioPortfolio

Nil

Location

Suite 11058 South Service Road
Melville
New York
11747
United States of America

Contact

Phone: (631) 962-2000
Fax: (631) 752-3880
Email: customer.service@gene.com


News Articles [9 Associated News Articles listed on BioPortfolio]

Tarceva Approved, PTV News: Apr 29, 2010

Roche lung cancer drug wins further EU approval

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Revision: 27, Authorised

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Revision: 28, Authorised

News Headlines, PTV News: Apr 29, 2010

A look at today's forthcoming news stories: Tarceva approved as non small cell lung cancer maintenance treatment, there are calls to halt Avandia clinical trial in the US, and turmeric could the spice...

Adding Bevacizumab to Erlotinib Prolongs PFS in EGFR-Mutated NSCLC

The combination of bevacizumab (Avastin) and erlotinib (Tarceva) is superior to erlotinib alone as upfront treatment for non–small cell lung cancer harboring EGFR mutations.

PTV News: Dec 17, 2009

Top stories on December 17th, 2009: Mapping cancer: The genetic mutations that turn healthy cells into tumours OSI "could lose US $400M sales" after Tarceva's turned down Celgene's psoriasis s...

Garland Takes Helm Of Portola At A Crucial Time

Portola touts exec's commercial management experience with Genentech success stories Avastin and Tarceva.    

@AJ_biotecsponge Allison Johnson

It turns out handfuls of allosteric mutant oncogenes are targetable with a single inhibitor. Read how newco Black Diamond Therapeutics – co-founded by leaders behind first-gen TKI Tarceva alongside ...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Tarceva(erlotinib)tablets [OSI Pharmaceuticals Inc.]

TARCEVA(erlotinib)Tablets

Tarceva [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA (erlotinib hydrochloride) tablet for oral use In...

PubMed Articles [0 Results]

None

Clinical Trials [137 Associated Clinical Trials listed on BioPortfolio]

A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-Small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

This is a multicenter, open-label, randomized phase 1 study of escalating doses of Tarceva in patients with advanced NSCLC who currently smoke. Part I will establish the maximum tolerated...

Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

The purpose of this study is test the safety of Tarceva, find the best dose, and see what effects (good and bad) it has on you and your colorectal cancer. The effects of Tarceva will be e...

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

This is a phase II study of Bevacizumab plus Temodar and Tarceva in patients with non-progressive glioblastoma or gliosarcoma. Patients must have stable disease immediately following a sta...

A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer

This study is designed to identify biomarkers which may predict improvement in progression free survival from treatment with Tarceva, in patients with advanced pancreatic cancer who failed...

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

This study will compare the efficacy and safety of escalating versus standard doses to rash of Tarceva, in combination with gemcitabine, in patients with metastatic pancreatic cancer. Duri...

Companies [3 Associated Companies listed on BioPortfolio]

TARCEVA

Nil

OSI Pharmaceuticals

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality o...

Hana Biosciences, Inc.

Hana Biosciences, Inc. (Nasdaq: HNAB) is a biopharmaceutical company dedicated to developing new, differentiated cancer therapies designed to improve and enable current standards of care. The Com...

More Information about "TARCEVA" on BioPortfolio

We have published hundreds of TARCEVA news stories on BioPortfolio along with dozens of TARCEVA Clinical Trials and PubMed Articles about TARCEVA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TARCEVA Companies in our database. You can also find out about relevant TARCEVA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record